COVID-19 Therapeutics Programme
The National Institute for Health Research (NIHR) has awarded funding to the University of Oxford - working with several UK universities - to carry out a first-of-its-kind clinical trial, testing novel antiviral coronavirus (COVID-19) treatments for use early in the illness, by people in the community with COVID-19 who are at higher risk of complications.
The PANORAMIC Trial is a national priority trial. They are recruiting volunteers, whether they have been vaccinated or not. It is open to everyone with ongoing symptoms of COVID-19 and a positive polymerase chain reaction (PCR) test or Lateral Flow Test (LFT).
NHS England and the Department of Health and Social Care have commissioned NHS Digital to provide a solution to find people who would be eligible for the trial. A secure web viewer will be available to a person’s GP practice and GP Hubs (GPs) for this. It will run as a new service to enable GPs to access lists of their registered patients, who are eligible for trial participation based on the defined inclusion criteria. The GP will make contact with the patient with the intention of the GP recruiting them for the trial.
GPs (the Recipients) are Controllers (as defined in UK GDPR) for the above purposes.
Confidential nature of the information requested
NHS Digital is the Controller for the data which is to be shared with the Recipients.
The data is identifiable patient information and is comprised of information that has been obtained by the NHS and NHS Digital, in confidence. It also provides information about the health of the patients. The data is, therefore, confidential information and subject to a duty of confidence under the common law (Duty of Confidence).
Agreed Purposes for sharing the requested data
The purposes for sharing the requested data are set out below.
NHS Digital has agreed to share the data below (the Disclosed Data) about patients’ with their GP:
- NHS number
- date of birth
- date and time of positive polymerase chain reaction (PCR) test or lateral flow test (LFT)
- contact information, mobile number and email address, provided by the patient or their representative/guardian at the point of booking their PCR test or registering their LFT
- contact information mobile number and email address from the patients’ medical record
- the clinical condition group
The Recipients will only receive the Disclosed Data for their patients registered with the GP.
Recipients will use the Disclosed Data for the purpose of contacting patients to discuss participation in the Panoramic Trial. Recipients have been provided with consent materials by the Panoramic Trial and will only forward information about the patient when the patient has given consent.
The Recipients will access the Disclosed Data via a secure web viewer on the NHS Digital Population Health Platform – GP Web Viewer (NHS Digital Web Viewer).
Legal basis for the recipients to receive the disclosed data
The Recipients are able to receive and process the Disclosed Data under a notice issued to the Recipients by the Secretary of State for Health and Social Care under Regulation 3(4) of COPI dated 27 August 2021 (the Recipients COPI Notice).
Under GDPR, the Recipients can rely on Article 6(1)(c) – Legal Obligation, to receive and process the Disclosed Data from NHS Digital for the Agreed Purposes under the legal authority set out above. As this is health information and therefore special category personal data the Recipient can also rely on Article 9(2)(h) – healthcare purposes and paragraph 2 of Schedule 1 DPA – health or social care purpose.
Last edited: 14 April 2022 11:51 am